N-terminal protype-B natriuretic peptide and Doppler diastolic variables are incremental for risk stratification of patients with NYHA class I-II systolic heart failure

Int J Cardiol. 2009 Aug 14;136(2):144-50. doi: 10.1016/j.ijcard.2008.04.032. Epub 2008 Jul 22.

Abstract

Background: In systolic heart failure (HF), preventing the development of severe symptoms, before patients are in advanced NYHA functional classes, is a worthwhile target of therapy. Early recognition of left ventricular (LV) diastolic dysfunction and neuroendocrine activation may have an important impact on patient's outcome.

Aim: To investigate whether N-terminal proBNP (NT-proBNP) and mitral flow and tissue Doppler (TD) diastolic parameters are incremental for risk stratification of systolic HF patients in NYHA class I and II.

Methods: The study consisted of 232 consecutive outpatients with systolic HF (ejection fraction [EF] <or=45%) in NYHA class I to II. They had a full Doppler two-dimensional-echocardiographic study, including pulsed-Doppler mitral E wave deceleration time (EDT) and TD early septal annular velocity (E'). Plasma NT-proBNP was assessed at the time of the echocardiogram.

Results: During a median follow-up of 31 months, there were 65 events (25 deaths and 40 HF-related hospitalizations). Multivariate analysis showed that N-terminal proBNP >544 pg/ml (hazards ratio [HR]: 2.66; p=0.012), EF <37% (HR: 2.45; p=0.006), E <or=8 cm/s (HR: 1.84; p=0.045) and EDT <150 ms (HR: 1.78; p=0.026) significantly correlated with events. On forward stepwise analysis, EDT (p<0.0001) and E' (p<0.0001) provided an incremental contribution to the outcome prediction above and beyond conventional risk markers, that was further increased by the addition of NT-proBNP (p<0.0001).

Conclusion: In patients with systolic HF in NYHA functional class I and II, N-terminal proBNP and LV mitral flow and TD variables of diastolic dysfunction had a strong predictive power for the combined end point of all-cause mortality and HF-related hospitalizations.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Diastole
  • Early Diagnosis
  • Echocardiography, Doppler*
  • Female
  • Follow-Up Studies
  • Heart Failure, Systolic* / blood
  • Heart Failure, Systolic* / diagnostic imaging
  • Heart Failure, Systolic* / mortality
  • Hospitalization / statistics & numerical data
  • Humans
  • Kaplan-Meier Estimate
  • Male
  • Middle Aged
  • Mitral Valve / diagnostic imaging
  • Natriuretic Peptide, Brain / blood*
  • Peptide Fragments / blood*
  • Predictive Value of Tests
  • Prognosis
  • Risk Factors
  • Systole

Substances

  • Peptide Fragments
  • pro-brain natriuretic peptide (1-76)
  • Natriuretic Peptide, Brain